(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Working out at the airport? Some fliers can already smell the sweat. - 2Map shows more than 1,900 measles cases across U.S.
- 3How to watch ‘The Traitors’ U.K. Season 4 premiere today from the U.S.
- 4Why screening for the deadliest cancer in the U.S. misses most cases
- 525 Years Ago, Audi's Rosemeyer Concept Was A Steampunk Supercar With A Massive Engine
- New York to require social media platforms to display mental health warnings
- Upgrading the Healthy benefit of Your Local Vegetables
- Euclid space telescope sees gorgeous cosmic cloud | Space photo of the day for Nov. 18, 2025
- Vote in favor of the Web-based Work out schedule to Keep You Fit and Sound
- Big Bear glows with big stars | Space photo of the day for Dec. 31, 2025
- Pick Your #1 Kind Of Treat
- 7 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Thorough Aide
- Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World
- 'Inflaming tensions': Bedouin mayor slams Ben-Gvir's unauthorized visit after meeting cancellation
